Nearly every protein therapeutic on the market is administered to patients with injections. Since proteins are inherently unstable in circulation and can be rapidly broken down, effective therapy often requires high doses be injected into the bloodstream.

This results in unwanted side-effect risks, higher drug costs, and increased patient discomfort.

Tenza's approach sidesteps these pain points.

Using computationally guided synthetic biology, we engineer probiotic microbes commonly found in fermented food like yogurt or kombucha to synthesize and deliver drugs directly to target tissue.

Going forward, Tenza sees a future that fully exploits microbial programmability to build smart microbes equipped with genetically encoded sensors that measure disease severity, and adjust dosing in real-time;

Thus streamlining diagnosis, prescription, and treatment into a single, efficient product.